CG MedTech Co.,Ltd. (KOSDAQ:056090)

CG MedTech Statistics

Total Valuation

CG MedTech has a market cap or net worth of KRW 223.04 billion. The enterprise value is 216.65 billion.

Market Cap	223.04B
Enterprise Value	216.65B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

CG MedTech has 103.26 million shares outstanding. The number of shares has increased by 73.05% in one year.

Current Share Class	103.26M
Shares Outstanding	103.26M
Shares Change (YoY)	+73.05%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	0.26%
Owned by Institutions (%)	n/a
Float	61.12M

Valuation Ratios

The trailing PE ratio is 34.29.

PE Ratio	34.29
Forward PE	n/a
PS Ratio	4.72
PB Ratio	2.37
P/TBV Ratio	2.68
P/FCF Ratio	n/a
P/OCF Ratio	85.37
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.71, with an EV/FCF ratio of -24.43.

EV / Earnings	33.29
EV / Sales	4.59
EV / EBITDA	35.71
EV / EBIT	56.98
EV / FCF	-24.43

Financial Position

The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.05.

Current Ratio	2.12
Quick Ratio	1.10
Debt / Equity	0.05
Debt / EBITDA	0.71
Debt / FCF	-0.49
Interest Coverage	21.57

Financial Efficiency

Return on equity (ROE) is 7.19% and return on invested capital (ROIC) is 4.62%.

Return on Equity (ROE)	7.19%
Return on Assets (ROA)	2.14%
Return on Invested Capital (ROIC)	4.62%
Return on Capital Employed (ROCE)	3.86%
Weighted Average Cost of Capital (WACC)	4.64%
Revenue Per Employee	393.62M
Profits Per Employee	54.23M
Employee Count	120
Asset Turnover	0.43
Inventory Turnover	1.91

Taxes

Income Tax	-3.77B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +134.14% in the last 52 weeks. The beta is 0.08, so CG MedTech's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	+134.14%
50-Day Moving Average	2,261.60
200-Day Moving Average	1,368.20
Relative Strength Index (RSI)	42.35
Average Volume (20 Days)	4,188,047

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CG MedTech had revenue of KRW 47.23 billion and earned 6.51 billion in profits. Earnings per share was 63.00.

Revenue	47.23B
Gross Profit	20.86B
Operating Income	3.80B
Pretax Income	2.74B
Net Income	6.51B
EBITDA	6.07B
EBIT	3.80B
Earnings Per Share (EPS)	63.00

Balance Sheet

The company has 10.84 billion in cash and 4.31 billion in debt, with a net cash position of 6.54 billion or 63.29 per share.

Cash & Cash Equivalents	10.84B
Total Debt	4.31B
Net Cash	6.54B
Net Cash Per Share	63.29
Equity (Book Value)	94.15B
Book Value Per Share	909.14
Working Capital	18.56B

Cash Flow

In the last 12 months, operating cash flow was 2.61 billion and capital expenditures -11.48 billion, giving a free cash flow of -8.87 billion.

Operating Cash Flow	2.61B
Capital Expenditures	-11.48B
Depreciation & Amortization	2.26B
Net Borrowing	-3.73B
Free Cash Flow	-8.87B
FCF Per Share	-85.87

Margins

Gross margin is 44.17%, with operating and profit margins of 8.05% and 13.78%.

Gross Margin	44.17%
Operating Margin	8.05%
Pretax Margin	5.79%
Profit Margin	13.78%
EBITDA Margin	12.84%
EBIT Margin	8.05%
FCF Margin	n/a

Dividends & Yields

CG MedTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-73.05%
Shareholder Yield	-73.05%
Earnings Yield	2.92%
FCF Yield	-3.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 5, 2022. It was a forward split with a ratio of 5.

Last Split Date	Aug 5, 2022
Split Type	Forward
Split Ratio	5

Scores

CG MedTech has an Altman Z-Score of 3.12 and a Piotroski F-Score of 5.

Altman Z-Score	3.12
Piotroski F-Score	5